NEW YORK , March 10 (GenomeWeb News) - Antara Biosciences has licensed from Toshiba patents to its DNA chips and electrochemical DNA analysis system for in vitro diagnosis, Toshiba said today.
Under the agreement, Antara, a California-based company started by the Tokyo-based Eurus Genomics, will develop the products for US Food and Drug Administration approval.
Toshiba said the deal "is a major step ... toward establishing the methadology as a core methodology for DNA-based diagnostics."
Financial details were not released.